GTC Biotherapeutics (fka GTCB)

[shears]

Blah, blah, blah blah blah....

Bottom line is NO IMPROVEMENT IN MORTALITY!!! This meaningless little outcome is finally reported on page 6!!! (table 4).

That's the whole purpose of improving outcomes in DIC and sepsis or whatever else causes DIC, is it not? So what if you can make some DIC numbers look better or show lower bleeding than heparin, the goal is to save lives. This stuff sucks. The FDA would be stupid to approve an agent like this. It won't happen.